BEIJING, March 3, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) (“Dehaier” or the “Company”), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2010 on Monday, March 7, 2011 before the start of trading in the United States.
(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO )
Company management will host a conference call for investors on Monday, March 7, 2011 at 8:30 a.m. EST. Interested parties may access the call by dialing (877) 941-2321 in the U.S. and Canada, or (480) 629-9714 internationally, approximately 10 minutes prior to the scheduled start time.
A replay of the call will be available approximately two hours after the conclusion of the live call, through March 21, 2011. The replay can be accessed by dialing 800-406-7325 in the U.S. and Canada, or 303-590-3030 internationally and entering the passcode: 4417849#.
The call will also be available as a live, listen-only webcast on the Company’s website at http://www.chinadhr.com. Following the live broadcast, an archive will be available for one year.
About Dehaier Medical Systems Ltd.
Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices and respiratory and oxygen homecare products from IMD (Italy), Welch Allyn (USA) and HEYER (Germany), Timesco (UK), ResMed (Australia), and JMS (Japan). Dehaier’s technology is based on two patents, six pending patents, and proprietary technology. More information may be found at http://www.chinadhr.com.
Forward-looking Statements
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Contact Us | |
In the US: The Piacente Group, Inc. | |
In China: The Piacente Group, Inc. Investor Relations Wendy Sun Tel: +86-10-6590-7991 Email: dehaier@tpg-ir.com | |
Dehaier Medical Systems Limited Rita Liu CFO Tel: +86-10-8844-5026 Email: liuz@dehaier.com.cn | |
Anan Liu Investor Relations Manager Tel: +86-10-5166-0080 x169 Email: liuanan@dehaier.com.cn | |
SOURCE Dehaier Medical Systems Ltd.
